Similar to several other viruses, human T cell leukemia virus type I (HTLV-I) induces the formation of multinucleated giant cells (also known as syncytium) when amplified in tissue culture. These syncytia result from the fusion of infected cells with uninfected cells. Due to the intrinsic difficulty of infecting cells with cell-free HTLV-I virions, syncytium formation has become an important tool in the study of HTLV-I infection and transmission. Since most HTLV-I-based cell fusion assays rely on the use of non-T cells, the aim of this study was to optimize a new HTLV-I-induced cell fusion assay in which HTLV-I-infected T cell lines are co-cultured with T cells that have been transfected with an HTLV-I long terminal repeat (LTR) luciferase reporter construct. We demonstrate that co-culture of various HTLV-I-infected T cells with different transfected T cell lines resulted in induction of luciferase activity. Cell-to-cell contact and expression of the viral gp46 envelope protein was crucial for this induction while other cell surface proteins (including HSC70) did not have a significant effect. This quantitative assay was shown to be very sensitive. In this assay, the cell fusion-mediated activation of NF-nB and the HTLV-I LTR occurred through previously described Tax-dependent signaling pathways. This assay also showed that cell fusion could activate Tax-inducible cellular promoters. These results thus demonstrate that this new quantitative HTLV-I-dependent cell fusion assay is versatile, highly sensitive, and can provide an important tool to investigate cellular promoter activation and intrinsic signaling cascades that modulate cellular gene expression. D
Introduction
HTLV-I is the etiological agent of adult T cell leukemia/ lymphoma (ATLL) and tropical spastic paraparesis (TSP) also known as HTLV-I-associated myelopathy (HAM) (Gessain et al., 1985; Osame et al., 1986; Poiesz et al., 1980) . Other documented complications associated with this virus include uveitis, cutaneous lymphoma, arthritis, and Sjö gren's syndrome (Manns et al., 1999; Masuko-Hongo et al., 2003; Watanabe, 1997) . Although this virus is prevalent in certain areas of Japan, very few infected individuals (from 2% to 5%) develop symptoms associated with HTLV-I infection. Furthermore, most of these associated diseases take decades to develop following infection. Because of the long clinical latency associated with HTLV-I infection, there is a lack of information regarding the onset of these illnesses as well as the mode of virus replication. However, it is known that in vivo HTLV-I proviral DNA is predominately found in CD4+ and CD8+ T cells (Richardson et al., 1990) . 0042 In cell culture, it appears that HTLV-I tropism extends to other cell types or species of origin (Okuma et al., 1999; Trejo and Ratner, 2000) . Recent identification of the putative HTLV-I receptor, the GLUT-1 glucose transporter, may explain the ubiquitous nature of HTLV-I tropism in vitro (Manel et al., 2003a) .
It is well established that purified HTLV-I virions infect susceptible cells very inefficiently (Derse et al., 2001; Fan et al., 1992) and that transmission in cell culture is greatly improved when cell-to-cell contact is allowed. HTLV-Iinfected cells undergo cell-to-cell fusion events (also termed syncytia) in cell culture. Although their existence in vivo is debatable, the importance of syncytia in HTLV-I infection and the role of cell surface proteins in viral entry have been well documented. As in viral infection, the viral gp46 glycoprotein mediates cell fusion by serving as the receptor interacting molecule and allows subsequent exposure of the fusion peptide to the viral gp21 transmembrane protein (Le Blanc et al., 2001; Sommerfelt, 1999) . In addition to interaction of the cell receptor with gp46, other cellular proteins are likely to contribute to syncytium formation. It has been suggested that the heat shock cognate protein 70 (HSC70) might be an important player in HTLV-I-induced syncytium formation (Sagara et al., 1998) . Similar to anti-gp46-blocking antibodies or sera from HTLV-I-seropositive patients, antibodies against certain other molecules also inhibit HTLV-I-induced syncytium formation (Daenke et al., 1999; Nagy et al., 1983; Okuma et al., 1999) . For example, the use of antibodies against vascular cell adhesion molecule-1 (VCAM-1) and major histocompatibility complex class II (MHC-II) suggests that those molecules play a role in cell-tocell fusion (Hildreth, 1998; Hildreth et al., 1997) .
The viral Tax protein is also likely to affect syncytium formation. Tax has been clearly implicated in HTLV-Iinduced cell transformation (Nerenberg et al., 1987) , as well as playing a crucial role in HTLV-I replication. Indeed, Tax enhances the binding of the CREB transcription factor to elements in the HTLV-I LTR termed Tax responsive element 1 (TRE1) Zhao and Giam, 1992) and also recruits CREB-binding protein (CBP) to these complexes (Kwok et al., 1996) . Because of its ability to activate CREB as well as the transcription factors NF-nB and SRF (Armstrong et al., 1993; Munoz and Israel, 1995; Yoshida, 1994) , Tax is an important modulator of cellular gene expression. Specifically, Tax modulates the expression of cell adhesion molecules (Owen et al., 1997; Valentin et al., 2001) , which are important factors in HTLV-I-mediated syncytium formation.
The study of HTLV-I-mediated syncytium formation requires maintenance of typical cell adhesion molecule interactions. Since several syncytium formation assays rely on non-T cells, we sought to develop a new quantitative system to evaluate HTLV-I-dependent syncytium formation in T cell lines. Using an HTLV-I LTR-dependent luciferase gene reporter system transfected into Jurkat T cells, we have quantitated the extent of syncytium formation between HTLV-I-producing T cell lines and Jurkat T cells by measuring luciferase activity. Our results show that this assay is very sensitive and provides a useful tool to study Tax-dependent modulation of cellular gene expression. The results further suggest that HSC70 is not important in this syncytium formation assay.
Results

Induction of HTLV-I LTR activity by co-cultured MT2 cells
Several assays have been designed to evaluate HTLV-I infection or HTLV-I-mediated cell-to-cell fusion events (Daenke et al., 1999; Igakura et al., 2003; Okuma et al., 1999) . With this in mind, we wanted to develop a sensitive and quantitative method to evaluate HTLV-I-dependent cell fusion events that would exclusively involve T-cell-derived lines. This is an important feature of our assay since T lymphocytes are considered to be the primary cell type to harbor HTLV-I proviral DNA in vivo (Richardson et al., 1990) . We reasoned that cell fusion in T lymphocytes might be easily quantitated using a construct containing the HTLV-I LTR regulating expression of the luciferase reporter gene (pHTLV-Luc). Hence, transfected cells that fuse with HTLV-I-infected cells should produce higher luciferase activity due to transactivation by the Tax protein provided by the infected cells.
To test whether co-culture could upregulate luciferase activity in T cells, we first incubated MT2 cells, which actively produce HTLV-I particles, with Jurkat cells that had been transfected with the pHTLV-Luc plasmid. Luciferase activity was measured at different time points following incubation. As presented in Fig. 1A , the addition of MT2 cells to pHTLV-Luc-transfected Jurkat cells resulted in a time-dependent induction of luciferase activity that reached a 48-h optimum of 114-fold and then diminished after 72 h of incubation. Induction of luciferase activity was detected as early as 8 h following co-culture, suggesting that the mechanism of induction involved cell-to-cell fusion processes as opposed to infection, which would require a longer time. To confirm these results, Jurkat cells transfected with pHTLV-Luc were cultivated for 24 h in the presence of HTLV-I-infected T cell lines producing viral particles (MT2) or not (C8166-45 and MT4). As shown above, the MT2 cell line induced luciferase activity, while the other non-producing cell lines had no effect on luciferase activity (Fig. 1B) . To further confirm the ability of HTLV-I-infected cells to induce luciferase expression in uninfected cells, two additional HTLV-I-infected cell lines (MJ and C91/PL) were co-cultured with Jurkat cells that had been transfected with pHTLV-Luc (Fig. 1C ). Increased luciferase activity was again observed following co-culture with both cell types although at the level of luciferase activation was variable. Although co-culture with C91/PL cells resulted in the greatest induction of luciferase activity, these cells were not used for further experiments due to their high degree of variation between experiments (171 T 82-fold). Co-culture of transfected Jurkat cells with 293T cells that had been transfected with two different HTLV-I proviral DNA clones (i.e., K30 or ACH) resulted in greater luciferase activity than when transfected Jurkat cells were co-cultured with 293T cells transfected with the empty vector.
Activation of the HTLV-I LTR by Tax involves the CREB transcription factor; however, Tax can also activate the NF-nB transcription factor. Therefore, we reasoned that cell-to-cell fusion should also induce NF-nB-dependent luciferase gene expression in Jurkat cells. Transfection of Jurkat cells with the pNF-nB-Luc reporter followed by culture in the presence of MT2 cells resulted in a rapid and strong induction of luciferase activity, similar to that observed with pHTLV-Luc ( Fig. 1D ). Similar results were obtained upon co-culture of MT2 cells with the Jurkatderived JnB cell line (Ouellet et al., 1999) , which contains a stably integrated pNF-nB-Luc (data not shown). Co-culture of MT2 cells with Jurkat cells transfected with the pnBTATA-Luc vector, which contains NF-nB-binding sites derived from the HIV-1 enhancer, also resulted in strong induction of luciferase activity. In contrast, co-culture of Jurkat cells transfected with pNFAT-Luc, which is poorly Tax responsive in Jurkat cells (data not shown), did not lead to a significant increase in luciferase activity.
To determine whether other T cell lines could be used in this system, SupT1 and Jurkat-derived J.RT3 and J45.01 cells were transfected with pHTLV-Luc and cultured in the presence of MT2 cells. MT2-dependent activation of luciferase gene expression was again observed in all of the transfected T cell lines ( Fig. 1E ), although variations were noted among the different cell lines tested. These results demonstrate that co-culture with HTLV-I-producing cells leads to activation of the HTLV-I LTR in various T cell lines. These data further suggest that a cell fusion-dependent phenomenon permits intracellular Tax-dependent activation of luciferase gene expression.
Direct contact between cells is necessary for increased intercellular luciferase activity
As suggested above, given the short length of time required to induce HTLV-I LTR activity in Jurkat cells, cell fusion events triggered by co-culture with MT2 cells are likely the determining events in this upregulation of luciferase gene expression. However, soluble factors released from MT2 cells (for example, Tax) might also contribute to HTLV-I LTR activity.
To demonstrate that cell fusion events were required to modulate luciferase activity, we investigated the importance of cell-to-cell contact in this process. Specifically, the luciferase activity from co-cultures of pHTLV-Luc-transfected Jurkat cells with MT2 cells was compared to transfected Jurkat cells cultured with cell-free MT2 supernatant ( Fig. 2A ). Co-culture with MT2 cells again increased luciferase activity in transfected Jurkat cells, while cell-free MT2 supernatant did not affect luciferase activity. To further establish the requirement for cell-to-cell contact, co-cultured cells were incubated in the presence of dextran sulfate, a highly charged molecule that blocks cell fusion by causing repulsion of cells from one another ( Fig. 2B ). DEAEdextran was used as a control because it has a reduced ability to block cell fusion. Both of these agents were added to the medium of Jurkat and MT2 co-cultures at subcytotoxic concentrations (i.e., 100 Ag/ml or lower). The addition of dextran sulfate to Jurkat and MT2 co-cultures resulted in a gradual but significant decrease in luciferase activity with a maximal reduction of 93%. High DEAE-dextran concentrations had minimal effects on luciferase activity in these co-cultures. No decrease in luciferase activity was observed when transfected Jurkat cells alone were treated with similar concentrations of dextran sulfate (data not shown).
To confirm the importance of cell contact between MT2 and transfected Jurkat cells in the induction in luciferase activity, we used Falcon inserts containing a chamber with a membrane allowing exclusive diffusion of low molecular weight molecules (Fig. 2C ). Jurkat cells were positioned in the bottom of the well and MT2 cells were added to the insert chamber, which was then placed in the well. As a control, Jurkat cells were directly co-cultured in wells with MT2 cells. To determine whether the insert itself affected HTLV-I LTR activity in Jurkat cells, bpV[pic], a phosphotyrosine phosphatase (PTP) inhibitor, which we have previously demonstrated to be a powerful activator of HTLV-I transcription (Langlois et al., 2004) , was added to the insert chamber overlaying transfected Jurkat cells. Luciferase activity was determined after 8 and 24 h of incubation at these different experimental settings. We first demonstrated that addition of bpV[pic] to the insert activated the HTLV-I LTR in Jurkat cells to levels comparable with those observed in cells treated directly with the PTP inhibitor. In contrast, the increased luciferase activity observed in pHTLV-Luc-transfected Jurkat cells directly co-cultured with MT2 cells was attenuated in the insert and luciferase activity returned to basal level (trans- fected Jurkat cells alone). When both bpV[pic] and MT2 cells were added to transfected Jurkat cells, a greater increase in luciferase activity was observed, as expected. Addition of MT2 cells and bpV[pic] to an insert overlaying transfected Jurkat cells resulted in decreased luciferase activity, similar to luciferase activity measured in bpV[pic]-treated Jurkat cells in the absence of MT2 cells. Overall, these results strongly suggest that modulation of HTLV-I LTR activity observed in co-cultures depends on a fusion event between MT2 and Jurkat cells.
HTLV-I-specific fusion events are required for HTLV-I LTR activation
Since cell fusion is necessary for the increase in HTLV-I LTR activity, we next asked whether simple fusion events were sufficient to augment luciferase activity independent of possible intercellular transfer of Tax protein. Jurkat cells were transfected with either the pLTRX-Luc or pHTLV-Luc plasmids, containing the HIV-1 and HTLV-I LTRs, respectively. These cells were then co-cultured with cells chronically infected with HIV-1 (H9HIV IIIB ) or HTLV-I (MT2) ( Fig. 3 ). As demonstrated above, co-culture of MT2 cells with Jurkat cells transfected with the pHTLV-Luc plasmid (panel A) resulted in a time-dependent increase in luciferase activity. Consistent with the fact that the HIV-1 Tat protein does not activate the HTLV-I LTR, no such increase was observed following co-culture with the HIV-1-infected H9HIV IIIB cell line. Syncytium formation was nonetheless visually observed in these co-cultures. Co-cultures of Jurkat cells transfected with pLTRX-Luc (panel B) formed syncytia, which paralleled the ability of H9HIV IIIB cells to induce luciferase activity via the HIV-1 Tat protein (Barbeau et al., 1998) . MT2 cells were also able to increase luciferase activity in these transfected Jurkat cells, which is attributed to Tax-dependent activation of the HIV-1 LTR through NF-nB. These results demonstrate that HTLV-I-specific fusion events account for the increased luciferase activity in our coculture assay and that simple fusion events are not sufficient to induce HTLV-I-LTR activity.
Increased luciferase activity is blocked by anti-gp46 antibodies
To clearly address the involvement of HTLV-I-dependent cell fusion in the activation of luciferase activity in our cocultures, we used an anti-gp46 antibody (LAT 27), which has been shown to neutralize both gp46-dependent syncytium formation and HTLV-I infection (Tanaka et al., 1991) . Addition of increasing concentrations of the antibody to cocultures of pHTLV-Luc-transfected Jurkat cells and MT2 cells reduced luciferase activity up to 94% at the highest concentration tested (20 Ag/ml) ( Fig. 4A ). Luciferase activity was not affected when transfected Jurkat cells were incubated in the presence of equal antibody concentrations. Blocking experiments were also performed with other anti-gp46 antibodies known to diminish cell fusion (0.5a monoclonal antibody or SP-2, 3/4A antiserum) (Matsushita et al., 1986; Palker et al., 1992) . Incubation of co-cultured cells with these antibodies reduced luciferase activity, albeit to a lesser degree than LAT 27 ( Fig. 4B ).
Previous data suggested that the HSC70 cell surface protein may mediate cell-to-cell fusion events (Fang et al., 1999; Sagara et al., 1998 Sagara et al., , 2000 . Given the importance of this phenomenon, we used our cell fusion assay to determine whether Jurkat cells depended on HSC70 expression to fuse with MT2 cells. LAT 27-or SPA815 (anti-HSC70)-blocking antibodies were added to co-culture experiments and, as a control, SIM.2 (anti-CD4) antibodies were also tested ( Fig. 4C ). Increasing concentrations of either anti-CD4 or anti-HSC70 antibodies had no effect on cell fusion-dependent induction of luciferase activity while LAT 27 strongly diminished the induction of luciferase activity. These results were not surprising since, similar to the study of Brighty and Jassal (2001) , HSC70 proteins were not observed on the surface of our Jurkat clone by FACS analysis (data not shown). Blocking antibodies against MHC class I and ICAM-1, two cell surface proteins that have been implicated in HTLV-I-mediated syncytium formation (Daenke et al., 1999; Furuse et al., 1992) , were also tested in this assay and did not cause a statistically significant diminution of luciferase activity (data not shown). These data indicated that HSC70 and other molecules previously implicated in syncytium formation are not crucial (at least in Jurkat cells) for HTLV-I-induced cell-to-cell fusion as determined using our quantitative syncytium formation assay.
To assess the importance of cell fusion in modulating HTLV-I LTR activity in a more physiologically relevant system, PBMCs were transfected with pHTLV-Luc and cocultured with MT2 cells at two different ratios. As expected, luciferase activity was increased in co-cultured PBMCs at both tested cell ratios (Fig. 4D ). Importantly, this induction was abrogated when the anti-gp46 antibody LAT 27 was added to the culture. These results demonstrated that MT2 cell-dependent induction of HTLV-I LTR activity occurred in PBMCs and was blocked by anti-gp46 antibodies. Cell surface proteins previously thought to be important for HTLV-I-mediated syncytium formation did not significantly contribute to cell fusion in our assay.
Sensitivity of the quantitative HTLV-I-mediated cell fusion assay
To determine the sensitivity of our quantitative HTLV-Imediated cell fusion assay, decreasing numbers of MT2 cells were incubated in the presence of Jurkat cells transfected with pHTLV-Luc or pNF-nB-Luc plasmids (Fig. 5 ). After 24 h of co-culture, it was observed that in general, incubation of as few as 4 Â 10 2 MT2 cells in the presence of 10 5 Jurkat cells (ratio MT2/Jurkat 1:256) was sufficient to confer a measurable augmentation of the luciferase signal driven by the HTLV-I LTR (Fig. 5A) . This signal increased with the number of added MT2 cells up to a 1:32 cell ratio. A similar trend was observed in Jurkat cells transfected with the pNF-nB-Luc plasmid, where as few as 2 Â 10 2 MT2 cells per 10 5 Jurkat cells (1:512) caused a statistically significant increase in luciferase activity (Fig. 5B) . These results demonstrated that the present cell fusion assay is very sensitive and requires a low number of infected cells for activation to be measured.
CREB-binding sites within the HTLV-I LTR are required to induce luciferase activity
We next used this quantitative cell fusion assay to confirm the Tax-dependent mechanism of HTLV-I LTR activation. Previous studies have clearly shown that CREB- binding sequences within the TRE1 repeats are required for Tax-mediated LTR activation. Therefore, we reasoned that these elements played an important role in our assay. To test this possibility, we used various HTLV-I LTR-containing constructs in our assay. Luciferase reporter plasmids containing an LTR-derived fragment with all three TRE1 repeats and either the minimal SV40 promoter or a TATA box (pGL2-promoter HTLV(À325/À57) and pGL2tata HTLV(À325/À57), respectively) were transfected into Jurkat cells and co-cultured with the MT2 cells. The addition of MT2 cells resulted in maximal 47-fold or 203fold increases in luciferase activity in Jurkat cells transfected with pGL2-promoter HTLV(À325/À57) and pGL2tata HTLV(À325/À57), respectively (Fig. 6A) . To further address the importance of TRE1 sequences in intercellular LTR activation, Jurkat cells were transfected with LTR constructs mutated at all three CREB-binding sites within the TRE1 repeats (pGL3 21PMD/11T). These mutations greatly attenuate Tax induction of HTLV-I LTR activity (Langlois et al., 2004) . Jurkat cells were transfected with the wild-type pGL3 U3R construct or the TRE1-mutated pGL3 21PMD/11T construct and then co-cultured with various numbers of MT2 cells for 24 h. Compared to the wild-type LTR construct, the mutant LTR was much less responsive to activation upon co-culture with MT2 cells (Fig. 6B ). In fact, upon co-culture, the calculated fold inductions in Jurkat cells transfected with pGL3 21PMD/11T was less than 10% when compared to fold inductions measured in pGL3 U3Rtransfected cells. In these experiments, luciferase activity (including transfected Jurkat cells incubated alone) tended to be higher than in experiments conducted with the pHTLV-Luc vector (see, for example, Fig. 5A ). However, MT2-mediated induction of luciferase activity was comparable. These results demonstrate that LTR activation induced by MT2-dependent cell fusion was Tax-dependent and regulated by the typical CREB-dependent mechanism of HTLV-I LTR activation.
Use of the quantitative HTLV-I-driven cell fusion assay to analyze Tax-dependent modulation of gene expression
Tax activation of various transcription factors and cellular genes is an important feature of HTLV-I infection and pathogenesis. We thus wanted to determine whether our assay could be used to test mechanistic aspects of Tax- Transfected Jurkat cells were subsequently cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:1024, 1:512, 1:256, 1:128, 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell extracts were measured for luciferase activity. Depicted luciferase activities are the mean of 3 different measured samples TSD. Fold induction for each cell ratio is indicated above each column. This experiment is representative of 3 independent experiments. Fig. 6 . The CREB-binding sites in the TRE1 repeats are required for HTLV-I LTR activation following co-culture. (A) Jurkat cells were transfected with 15 Ag of pGL2tata HTLV(À325/À57) or pGL2-promoter HTLV(À325/ À57). Transfected cells were cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). (B) Jurkat cells were transfected with 15 Ag of pGL3 U3R or pGL3 21PMD/11T. Transfected cells were cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell extracts were measured for luciferase activity. Depicted luciferase activities are the mean of 3 different measured samples TSD. This experiment is representative of 3 independent experiments. dependent gene regulation. We were first interested in studying the direct activation of transcription factors by Tax.
To determine whether our assay would be suitable to understand pathways involved in transcription factor activation, we analyzed the well-characterized activation of NF-nB by Tax. Jurkat cells were co-transfected with pNF-nB-Luc and a dominant-negative InBa mutant expression vector (InBaSer32-36/Ala). This dominant-negative mutant has been previously shown to block NF-nB activation by being resistant to IKK-induced phosphorylation and ubiquitin-mediated degradation (Sun et al., 1996) . As controls, the empty vector and wild-type InBa expression vectors were independently transfected in Jurkat cells along with pNF-nB-Luc. As depicted in Fig. 7A , addition of different numbers of MT2 cells upregulated luciferase activity in all transfected Jurkat cells. However, when compared to other transfected Jurkat cells, induction of luciferase activity was reduced in co-cultured Jurkat cells expressing the dominantnegative InBa mutant. To examine the role of previously characterized mediators of Tax-dependent NF-nB activation in our assay, an upstream effector was tested in our cell fusion-based quantitative assay. Previous studies have demonstrated the importance of NF-nB-inducing kinase (NIK) in NF-nB activation as well as its role in Taxmediated activation (Geleziunas et al., 1998; Hiscott et al., 1997) . To confirm these findings Jurkat cells were transfected with a dominant-negative NIK KKA mutant expression vector and pNF-nB-Luc. Regardless of the cell ratio tested, expression of the dominant-negative NIK mutant reduced NF-nB-dependent luciferase expression when compared to Jurkat cells co-transfected with the empty vector ( Fig. 7B) . No effect on MT2-mediated induction of luciferase activity was observed in Jurkat cells co-transfected with pHTLV-Luc or any of the dominant-negative mutant expression vectors tested in Jurkat cells ( Fig. 7B and data not shown).
We also investigated whether Tax-dependent modulation of cellular gene expression could be analyzed using our system. To address this possibility, two genes known to be activated by Tax, ICAM-1 and RANTES (Mori et al., 2004; Owen et al., 1997) , were studied. Constructs containing either the human ICAM-1 or RANTES promoters positioned upstream of the luciferase gene were transfected into Jurkat cells. Transfected Jurkat cells were cultured in the presence of different MT2 cell concentrations. Addition of MT2 cells clearly augmented luciferase activity in the transfected Jurkat cells (Fig. 8) . This increase was blocked by the addition of anti-gp46 LAT 27 antibodies (data not shown). These results indicated that cell fusion-induced NF-nB activation occurred through the previously described Tax-dependent pathway making this system useful in the Fig. 7 . InBa and NIK dominant-negative mutants block MT2-mediated NF-nB activation. (A) Jurkat cells were co-transfected with 7.5 Ag of pNF-nB-Luc and 7.5 Ag of pCMV4-HA (empty vector), pCMV4-HA-InBa WT, or pCMV4-HA-InBa S32/36A. Transfected cells were cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). (B) Jurkat cells were co-transfected with 7.5 Ag of pNF-nB-Luc or pHTLV-LUC and 7.5 Ag of pRKmyc-HA (empty vector), or pRKmyc NIK KK(429-430)AA. Transfected cells were cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:128, 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell extracts were measured for luciferase activity. Luciferase activities were calculated as the mean of 3 different measured samples TSD. For each transfections and co-culture conditions, fold inductions were obtained from the mean value of transfected cells cultured in the presence of MT2 cells divided by the mean value of transfected cells alone. This experiment is representative of 3 independent experiments. Fig. 8 . Induction of ICAM-1 and RANTES promoter activity upon coculture with MT2 cells. Jurkat cells were transfected with 15 Ag of pGL1.3Luc (ICAM-1 promoter) or pRANTES0.9Luc. Transfected Jurkat cells were subsequently cultured alone or with two-fold dilutions of the number of added MT2 cells (ratios of 1:256, 1:128, 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell extracts were measured for luciferase activity. Depicted luciferase activities are the mean of 3 different measured samples TSD. This experiment is representative of 3 independent experiments. study of Tax-mediated signal transduction pathways. Taxresponsive cellular genes showed similar levels of activity in our quantitative cell fusion assay.
Discussion
Studies on HTLV-I-dependent syncytium formation have been generally limited to non-T cell lines. However, since most HTLV-I-infected cells in humans are T lymphocytes, a more representative system to measure HTLV-I-induced cell fusion events should utilize human T cell lines. In addition, since microscopic quantitation of syncytia is not accurate, we wanted to develop a sensitive, reproducible, and quantitative enzymatic assay to measure HTLV-I-dependent cell fusion events in T lymphocytes. The luciferase reporter gene was most suitable for our assay due to the ease and sensitivity of measuring its activity. Several systems have been previously described to measure HTLV-I-induced syncytium formation and the luciferase reporter gene has been used with T7 RNA polymerase to quantitate syncytia (Okuma et al., 1999) . Our assay, which takes advantage of intracellular Tax in HTLV-I-infected cells, is based on the activation of a luciferase reporter gene under the control of a Tax-inducible promoter (i.e., the HTLV-I LTR) following fusion with HTLV-I-infected cells.
Our initial results demonstrated that NF-nB-and HTLV-I LTR-dependent transcription was activated in Jurkat T cells following co-culture with HTLV-I-infected cells (MT2, MJ, and C91/PL) in a time-dependent fashion. The increased luciferase activity was constant up to 48 h, and thus was somewhat slower than the similarly designed HIV-1-based syncytium assay. This might be due to lengthier time needed for optimal fusion of HTLV-I-infected cells after which the drop in luciferase activity likely represents syncytiuminduced cell death and loss of luciferase-expressing cells. These results parallel the increase observed upon co-culture with non-T 293T cells transfected with HTLV-I proviral DNA. The low response of Jurkat cells to MJ cells is likely due to low production of viral particles from this cell line as compared to other HTLV-I-producing cell lines used in this study (data not shown), which would make MJ less fusogenic. Increased luciferase activity was not observed when transfected Jurkat cells were co-cultured with HTLV-Iinfected non-producing MT4 and C8166-45 cell lines that do not express gp46 on their surface. Luciferase gene expression was also induced upon co-culture with other transfected T cell lines suggesting that the observed induction (especially as early as 8 h after co-culture) depended on cell fusion and not on viral infection. Several approaches were used to confirm that the upregulation of luciferase gene expression resulted from cell fusion events. We showed that cell-to-cell contact was required through the use of Dextran sulfate and membrane inserts. These results are consistent with the fact that supernatant from MT2 cells did not efficiently induce HTLV-I LTR activity. This is an important issue since extracellular Tax has been reported to induce T cell activation and NF-nB translocation in T cell lines or PBMCs (Lindholm et al., 1990; Marriott et al., 1991) . Using anti-gp46 antibodies, we demonstrated that the induction depended on gp46-mediated cell fusion. However, cell-to-cell fusion events were not sufficient to induce HTLV-I LTR regulated luciferase gene expression as judged by the use of a fusion competent HIV-1-infected cell line. These data are consistent with an obligatory fusion step between MT2 and Jurkat cells to activate the LTR. Luciferase upregulation in transfected PBMCs was confirmed using co-culture experiments with MT2 cells. Since these PBMCs were not stimulated by antigen, it is likely that HTLV-I receptor expression was modest, as previously reported (Manel et al., 2003b) , thereby contributing to the reduced MT2-dependent activation of luciferase expression compared to transfected Jurkat cells.
In these experiments, we also tested antibodies against various cell surface proteins known to be important for viral infection or HTLV-I-mediated cell fusion. For example, anti-HSC70 antibodies did not effectively block cell fusion events as determined by luciferase activity. Although these results contradict previous work suggesting that these antibodies do block HTLV-I-mediated syncytium formation (Fang et al., 1999; Sagara et al., 1998) , a more recent study was also unable to demonstrate the involvement of HSC70 in Jurkat-MT2 cell fusions (Brighty and Jassal, 2001) . Blocking antibodies against ICAM-1 also had no effect on syncytium formation. This result also contradicts a report in which ICAM-1 expression in K562 cells augmented syncytium formation with MT2 cells (Daenke et al., 1999) . Anti-ICAM-1 antibodies have also been reported to block syncytium formation in C91/PL/MOLT4 cell co-cultures . These data reinforce the notion that HTLV-I-induced cell fusion or syncytium formation should be studied in T cell lines. These results also demonstrate the utility of this quantitative cell fusion assay in testing antibodies against specific membrane receptors to assess their involvement in HTLV-I-mediated cell fusion.
Our results demonstrated that this assay was sensitive and required a limited number of HTLV-I-infected cells to measure incremental luciferase activity following co-culture with MT2 cells. However, in general, the highest MT2/ Jurkat cell ratios led to lower induction of luciferase activity. Although the explanation for this observation is unknown, potential soluble factors (such as cell supernatant-associated soluble gp46) produced by MT2 cells may block cell fusion events. The lower sensitivity of the pNF-nB-dependent signal might depend on other supernatant-associated soluble factors that activate NF-nB. This would further justify the use of pHTLV-Luc as the fusion indicator vector, as it is less likely to be sensitive to these types of soluble factormediated activation.
Dominant-negative mutant expression vectors and TRE1-mutated HTLV-I LTR reporters suggested that LTR activation following cell fusion occurred through a pathway similar to that described for intracellular Tax-mediated activation. The ability of Tax to induce luciferase activity was further illustrated by the absence of induction in pNFAT-Luc-transfected cells, confirming our finding that Jurkat cells transfected with this vector were not induced following co-transfection of a Tax-expression vector (data not shown). In addition, recent results from our group demonstrated that induction of Tax expression in Jurkatderived JPX/9 cells increased luciferase expression when these cells were co-cultured and induced to fuse with pHTLV-Luc-transfected Jurkat cells (unpublished results).
Since Tax-regulated cellular genes were also activated in this cell fusion assay, it could be a valuable tool for the study of Tax-dependent cellular gene regulation. Our system offers several advantages that makes it particularly well suited for this type of study. First, the assay permits parallel evaluation of Tax activation following co-culture of different HTLV-I-infected cell lines with transfected cells, although the fusogenic potential of each infected cell line may vary. Second, although this assay depends on cell fusion events, the signaling pathway appears to be consistent and, as opposed to the use of Tax expression vectors, the assay permits a more physiological analysis of Tax-dependent activation in terms of intracellular Tax levels and the presence of other HTLV-I proteins that may positively or negatively impact Tax function. Third, compared to transient transfection experiments, our assay might abolish potential effects of dominant-negative mutants on the promoter driving Tax expression.
In summary, we present a quantitative HTLV-I-mediated cell fusion assay consisting exclusively of T cell lines. This assay was found to be very sensitive and suitable for different uninfected and infected T cell lines. Variable induction of luciferase activity noted when different HTLV-I-infected and non-infected cells were tested is likely attributable to variable content of cellular and viral factors in the two partner cell lines used in the syncytium assays. However, experiments conducted with the same HTLV-Iinfected/non-infected cell partners showed reproducible induction of luciferase activity. We are currently using this assay to analyze Tax-mediated signal transduction pathways and to test antibodies that may potentially block cell fusion.
Materials and methods
Cell lines
Jurkat (clone E61) (Schneider et al., 1977) and SupT1 (Smith et al., 1984 ) CD4+ T lymphoid cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, MD). Jurkat-derived J.RT3 (Morley et al., 1988) and J45.01 (Koretsky et al., 1991) cell lines are deficient for cell surface T cell receptor and CD45 expression, respectively, and were kindly provided by Dr. R.T. Abraham (The Mayo Clinic, Rochester, MN) and Dr.
A. Weiss (Howard Hughes Medical Center, San Francisco, CA) . JnB was derived from Jurkat cells stably transfected with pNF-nB-Luc along with the pEFneo vector and has been previously described (Ouellet et al., 1999) . MT2 (Haertle et al., 1988) , MT4 (Harada et al., 1985) , C8166-45 (Salahuddin et al., 1983) , and C91/PL (Popovic et al., 1983) are all HTLV-I-infected T cell lines; however, only MT2 and C91/PL are capable of producing infectious HTLV-I particles. MT2, C91/PL, and C8166-45 cell lines were derived from cord blood lymphocytes while MT-4 was obtained directly from a patient with adult T cell leukemia. H9HIV IIIB (Popovic et al., 1984) is an H9-derived cell line chronically infected with HIV-1 IIIB . The C91/PL cell line was obtained from Dr. R. Sutton (Baylor College of Medicine, Houston TX), while other infected cell lines were provided by the NIH AIDS Research and Reference Reagent Program (Rockville, MD). All cell lines were maintained in RPMI-1640 complete culture medium supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT), 2 mM glutamine, 100 U/ml penicillin G, and 100 Ag/ml streptomycin and kept under neomycin selection when needed. Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples taken from healthy individuals by Ficoll-Hypaque density gradient centrifugation. Isolated PBMCs were resuspended in supplemented RPMI medium and directly used for transfection.
Plasmids pNF-nB-Luc is commercially available (Stratagene) and harbors five NF-nB-binding sites along with a minimal promoter upstream of the luciferase gene. The pnBTATA-Luc vector was kindly provided by Dr. W.C. Greene (The J Gladstone Institutes, San Francisco, CA) and contains the luciferase reporter gene under the control of a minimal promoter and the HIV-1 enhancer region (Sun et al., 1996) . The pNFAT-Luc vector contains the minimal IL-2 promoter positioned downstream of three tandem copies of an NFATbinding site and was kindly provided by Dr. G. Crabtree (Howard Hugues Medical School, Stanford CA) (Timmerman et al., 1996) . The pHTLV-Luc vector (also kindly provided by Dr. W.C. Greene) contains the complete HTLV-I LTR 3V region cloned into the XhoI/HindIII site of the pGL2-Basic luciferase vector (Promega) (Geleziunas et al., 1998) . The pGL3 U3R and pGL3 21PMD/11T plasmids were both derived by cloning a wild-type LTR (U3R) or the TRE1-mutated LTR (21PMD/11T) (Barnhart et al., 1997) into the XhoI/HindIII sites of the pGL3-Basic vector. The pGL2tata-Luc vector was constructed by subcloning a synthetic double-stranded oligonucleotide containing a TATA box and NheI/HindIII compatible ends (produced by hybridizing 5V-CTAGCGGGTATATAATGGATCCA-3V and 5V-AGCTTGGATCCATTATATACCCG-3Voligonucleotides) into the similarly digested pGL2-Basic vector (Promega). The pGL2tata HTLV(À325/À57) construct was then generated by cloning the SmaI/NdeI blunted fragment from the HTLV-I LTR into the SmaI site of the pGL2tata-Luc vector. A similar cloning procedure was used to introduce the HTLV-I LTR fragment into the SmaIdigested pGL2-promoter vector (Promega) generating pGL2-promoter HTLV(À325/À57). The pLTRX-Luc construct was generously provided by Dr. O. Schwartz (Pasteur Institute, Paris) (Schwartz et al., 1990) . Expression vectors for the wild-type and mutated InBa protein (pCMV4-HA-InBa WT or pCMV4-HA-InBa S32/36A, respectively), the dominant-negative NIK mutant (pRKmyc NIK KK(429-430)AA), and their corresponding empty vectors were kindly provided by Dr. W.C. Greene (Geleziunas et al., 1998; Sun et al., 1996) . The luciferase reporter vectors pGL1.3 and pRANTES0.9Luc are under the control of the ICAM-1 and RANTES promoters, respectively, and were kind gifts from Dr. M. Audette (Centre de recherche en endocrinologie moléculaire et oncologique, CHUQ, Pavillon CHUL, Ste-Foy, Canada) and from Dr. A.S. Fauci (National Institute of Allergy and Infectious Diseases, Bethesda, MD) (Moriuchi et al., 1997; Roy et al., 2001) . Complete HTLV-I proviral DNA producing fully infectious particles tested in the present study included K30 (Zhao et al., 1995) (obtained from the NIH AIDS Research and Reference Reagent Program, Rockville, MD) and ACH (Kimata et al., 1994) (kindly provided by Dr. Jean-Michel Mesnard, Laboratoires Infections Rétrovirales et Signalisation Cellulaire, CRBM-CNRS UPR 1086, Montpellier, France). The pSV2gpt vector was derived from K30 following excision of the proviral DNA.
Antibodies and reagents
The LAT 27 monoclonal antibodies specific for the HTLV-I gp46 envelope protein were derived from WKA rats immunized with a recombinant vaccinia virus expressing the gp46 (Tanaka et al., 1991) . Anti-Sp-2, 3/4A, and 0.5a antibodies specific for HTLV-I gp46 (Matsushita et al., 1986; Palker et al., 1992) and SIM.2 anti-CD4 antibodies (McCallus et al., 1992) were obtained from the NIH AIDS Research and Reference Reagent Program (Rockville, MD). The anti-HSC70 antibody, SPA815, was purchased from Stressgen (Victoria, Canada). Anti-MHC class I W6/32 monoclonal antibodies (Barnstable et al., 1978) were purified from the corresponding hybridoma (ATCC) supernatant using mAbTrap protein G affinity columns (Pharmacia LKB Biotechnology AB, Uppsala, Sweden). The anti-ICAM-1 RR1/1.1.1-blocking antibody was kindly provided by Dr. Robert Rothlein (Boehringer Ingelheim, Ridgefield, CT) (Rothlein et al., 1986) . DEAE-Dextran was purchased from Amersham Pharmacia Biotech while dextran sulfate was purchased from Sigma. BpV[pic], a bis-peroxovanadium protein tyrosine phosphatase inhibitor, was kindly provided by Dr. B.J. Posner (McGill University, Montreal, Canada) , and its preparation has been described previously (Posner et al., 1994) .
Transfections
Transient transfections of T cell lines were performed using the DEAE-Dextran method as previously described (Barbeau et al., 1997) . Briefly, 5 Â 10 6 cells were washed in TS buffer (137 mM NaCl, 25 mM Tris -HCl [pH 7.4], 5 mM KCl, 0.6 mM Na 2 HPO 4 , 0.5 mM MgCl 2 , and 0.7 mM CaCl 2 ) and resuspended in 0.5 ml TS containing 15 Ag of the indicated plasmid(s) and 500 Ag/ml DEAE-dextran (final concentration). The cell/TS/plasmid/DEAE-dextran mix was incubated for 25 min at room temperature. Thereafter, cells were diluted to a concentration of 1 Â 10 6 /ml using complete culture medium supplemented with 100 AM chloroquine (Sigma) and transferred into 6-well plates. After a 45-min incubation at 37 -C, cells were centrifuged, resuspended in complete culture medium, and incubated at 37 -C for 24 h. Transfection of PBMCs was performed as previously described (Hughes and Pober, 1996) . Following isolation, cells were concentrated to 3 Â 10 6 cells/ml and stimulated with phytohemagglutinin-L for 19 -20 h at 37 -C. Cells were then concentrated in complete RPMI medium to 2 Â 10 7 cells/ml and a 250-Al aliquot was electroporated with 15 Ag pHTLV-Luc plasmid in a 0.4-cm cuvette using a Bio-Rad electroporation device (250 V, 950 AF). Transfection of 293T cells was conducted as previously described. Briefly, cells were plated 16 h before transfection to reach a 50 -80% confluence the day of transfection and transfected with 5 Ag of DNA using the Clontech Transfection Kit (BD Biosciences). To minimize variation in plasmid transfection efficiencies, cells were transfected in bulk and were then separated into various treatment groups.
Co-culture experiments
Infected and uninfected transfected cells were first concentrated to 1 Â 10 6 cells/ml. 1 Â 10 5 uninfected cells were then mixed with an equal number of HTLV-I-infected cells (or in certain cases, HIV-1-infected cells) and incubated for 8 -72 h in 96-well plates. When different cell ratios were tested, the 1 Â 10 6 cell/ml concentration of infected cells was diluted two-fold and 100 Al samples of each dilution was added to 100 Al of Jurkat cells (1 Â 10 5 cells). In some experiments, LAT 27, anti-Sp-2, 3/4A, SIM.2, DEAE-Dextran, or Dextran Sulfate were added to the co-cultured cells at the indicated concentrations. As a control, transfected Jurkat cells were incubated alone or with an equal volume of MT2 supernatant harvested from 1 Â 10 6 MT2 cell/ml incubated for 24 h. For all experiments, co-cultured cells were lysed and luciferase activity was assessed with a microplate luminometer (MLX; Dynex Technologies, Chantilly, VA) as previously described (Barbeau et al., 1997; Cantin et al., 1997; Fortin et al., 1997) . Mean luciferase activity T standard deviation (SD) was calculated using luciferase activity from three independent and similarly treated co-cultured cell samples.
Cell culture inserts
Cells were mixed in Falcon cell culture inserts containing a chamber separated from the wells by a 0.4-AM membrane (Becton Dickinson, Franklin Lakes, NJ). Cells were initially concentrated to 1 Â 10 6 cells/ml. MT2 cells or an equal volume of medium (750 Al) was subsequently added onto the membrane of the chamber, which was inserted into a well of a 24-well plate containing an equal number of pHTLV-Luctransfected Jurkat cells. In certain samples, bpV[pic] (10 AM) was also added in the upper chamber of the insert. As a control, a similar number of MT2 and transfected Jurkat cells were directly co-cultured in 24-well plates without an insert. After 24, 48, or 72 h of incubation, 100 Al of transfected Jurkat cells was withdrawn from each condition and assessed for luciferase activity as described above.
